Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)

PHASE4CompletedINTERVENTIONAL

Enrollment

148

Participants

Timeline

Start Date

September 1, 2003

Primary Completion Date

August 1, 2004

Study Completion Date

August 1, 2004

Conditions

HypercholesterolemiaAtherosclerosis

Interventions

DRUG

Ezetimibe + Atorvastatin

oral tablets: ezetimibe 10 mg + atorvastatin 10 mg once daily for 6 weeks

DRUG

Atorvastatin

oral tablets: atorvastatin 10 mg + ezetimibe placebo once daily for 6 weeks

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Organon and Co

INDUSTRY

NCT00653796 - Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434) | Biotech Hunter | Biotech Hunter